[Human brucellosis vaccine obtained from the phenol-insoluble fraction of Brucella abortus strain B 19. Production, control, standardization].
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology / Q000302:isolation & purification* / Q000592:standards; D002004:Brucella Vaccine / Q000276:immunology / Q000302:isolation & purification* / Q000592:standards; D002003:Brucella abortus / Q000276:immunology*; D002006:Brucellosis / Q000517:prevention & control; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D006801:Humans; D008252:Macaca fascicularis; D051379:Mice; D010636:Phenols; D011786:Quality Control; D012995:Solubility
D000942:Antigens, Bacterial; D002004:Brucella Vaccine; D010636:Phenols
Vaccin de la brucellose humaine obtenu à partir de la fraction phénolo-insoluble de Brucella abortus souche B 19. Production, contrôle, standardisation.